Amarantus Bioscience Holdings Inc (AMBS)

[jason_luke]

ALL IN. IMO About to Soar on Announcement of Joint Venture with Commercial Wound Care Company (maybe MiMedX or another big player?) to Develop Engineered Skin Substitute. Publication of the the recent article, "Randomized, Paired-Site Comparison of Autologous Engineered Skin Substitutes and Split-Thickness Skin Graft for Closure of Extensive, Full-Thickness Burns" showed extremely impressive results. ESS has improved upon Apligraf by incorporating autologous keratinocytes and fibroblasts from the patient into their scaffold. Data from this study show that
autologous ESSs reduce harvesting of donor skin in
pediatric patients for closure of burn injuries involving
greater than 50% TBSA. This would presumably apply to adult patients as well. Decreased donor skin requirements means less donor site
morbidity, fewer skin-grafting operations, and fewer days in intensive care.

Get ready for blast off. AMBS.